News items related to: Research
-
Researchers Reveal Strategies Used by Big Pharma to Monopolize COVID-19 Drugs and Vaccines
Pharmaceutical companies took advantage of the COVID-19 pandemic, ensuring maximum profits and monopolies on life-saving vaccines and drugs, according to...
-
Patent-free, low-cost vaccines highly protective against severe COVID
A new analysis of 390,459 participants assessing 14 different COVID-19 vaccines has identified no significant difference in efficacy against both symptomatic and severe...
-
Same Meds, New Patents: What Do Activists Need to Know About Long-Acting Formulations?
Long-Acting Formulations (LAFs) have the potential to make treatment for hepatitis C (HCV) and tuberculosis (TB) easier to adhere to,...
-
MMA’s partners in Kazakhstan call for systemic changes to the country’s intellectual property and access to medicines framework in their annual report
Answer Foundation and Antihepatitis C Foundation, MMA’s partners in Kazakhstan, with technical support from ITPC-Ru, recently launched a comprehensive Annual...
-
COVID-19 Community Resource: resource for access to COVID-19 medical technology
COVID-19 has revealed – and drastically worsened – economic and social inequality on a global scale. Governmental decisions to prioritize...
-
New resource: COVID-19 timeline
Today, one year after the World Health Organization (WHO) officially declared COVID-19 as a pandemic (11 March 2020), we launch...
-
The next COVID-19 crisis: A vaccine apartheid endangering us all
The West bought billions of vaccines fast and cheap, leaving poorer nations waiting longer and paying more. Published by The...
-
New data demonstrates the impact of patents in Ukraine
2020 will be remembered for COVID-19. The scale of the pandemic highlights the urgent need to ensure equitable access to...
-
Report: 10 years of community-monitoring of ARV procurement in Russia
ITPCru has released its latest report, providing a yearly analysis of community-monitoring of ARV procurement. The 2019 report marks 10...
-
COVID-19 pandemic: ‘An opportunity of a lifetime’?
The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...
-
Global headlines: Potential COVID-19 drugs are over-priced
From the front page of Le Monde, to the Financial Times, Bloomberg, Al Jazeera and others, research demonstrating that potential...
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Drugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
